Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13 | 30 | 55 | 93 | 196 |
| Receivables | 30 | 25 | 27 | 46 | 90 |
| Inventories | 42 | 44 | 49 | 56 | 72 |
| TOTAL | $107 | $117 | $149 | $212 | $365 |
| Non-Current Assets | |||||
| PPE Net | 191 | 197 | 203 | 208 | 214 |
| Investments And Advances | 2 | 2 | 2 | 2 | 2 |
| Intangibles | 101 | 107 | 47 | 50 | 53 |
| TOTAL | $294 | $307 | $251 | $260 | $269 |
| Total Assets | $401 | $423 | $400 | $472 | $633 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 337 | 341 | 345 | 313 | 314 |
| Accrued Expenses | 65 | 397 | 312 | 233 | 164 |
| Other current liabilities | N/A | 1,123 | 1,123 | 1,096 | 1,077 |
| TOTAL | $1,647 | $1,981 | $1,820 | $1,641 | $1,555 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,647 | $1,981 | $1,820 | $1,641 | $1,555 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 622,894 | 26,422 | 26,357 | 26,357 | N/A |
| Common Shares | 56 | 26 | 26 | 26 | 26 |
| Retained earnings | -4,899 | -4,560 | -4,407 | -4,155 | -3,735 |
| TOTAL | $-1,246 | $-1,558 | $-1,419 | $-1,170 | $-921 |
| Total Liabilities And Equity | $401 | $423 | $400 | $472 | $634 |